Meeting
2018 Gastrointestinal Cancers Symposium
Efficacy and prognostic factor analysis in second-line chemotherapy for elderly patients with metastatic gastric cancer.
Authors
Ayaka Shoji
Osaka National Hospital, Osaka, Japan
Ayaka Shoji , Hiroko Hasegawa , Seiya Kato , Ryosuke Kiyota , Kazuma Shinkai , Taku Tashiro , Akio Ishihara , Tetsuya Iwasaki , Satoshi Tanaka , Tomofumi Akasaka , Yuko Sakakibara , Shoichi Nakazuru , Hisashi Ishida , Motohiro Hirao , Eiji Mita
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 143)
DOI
10.1200/JCO.2018.36.4_suppl.143
Abstract #
143
Poster Bd #
K3
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Prognostic factor analysis in third-line chemotherapy for elderly patients with metastatic gastric cancer.
First Author: Hiroko Hasegawa
Poster
2019 Gastrointestinal Cancers Symposium
REVIVE study: Prospective observational study of efficacy and safety in chemotherapy (CTx) after progREssiVe dIsease of niVolumab (NIV) thErapy for metastatic gastric cancer (mGC).
First Author: Yukiya Narita
Poster
2019 Gastrointestinal Cancers Symposium
HGCSG 1603: Phase II study of ramucirumab and irinotecan combination therapy as second-line treatment in patients with metastatic or advanced gastric cancer.
First Author: Atsushi Ishiguro
Poster
2018 ASCO Annual Meeting
A phase II study of perioperative intraperitoneal paclitaxel plus S-1/paclitaxel for curatively resectable gastric cancer with serosal invasion: The GAPS study.
First Author: Seiji Ito